title: Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element.
abstract: Heparanase up-regulation was documented in an increasing number of human carcinomas, associated with poor prognosis. The purpose of the current study was to identify mechanisms responsible for heparanase induction. We provide evidence that heparanase expression is regulated at the post-transcriptional level by sequences at the 3' untranslated region (3' UTR) of the gene. Constructing the 3' UTR immediately following the heparanase cDNA reduces heparanase enzymatic activity and protein levels, resulting in decreased cellular invasion capacity. We further identified a 185-bp sequence within the 3' UTR that mediates heparanase down-regulation, and characterized an adenine (A)/uracil (U)-rich consensus element (ARE) within this region. Deletion of the entire 185-bp region or the ARE eliminated the inhibitory effect of the 3' UTR, resulting in elevated heparanase levels and formation of larger tumor xenografts indistinguishable from those produced by heparanase-overexpressing cells in terms of size, vascularization, and Akt activation. These results suggest that loss of the ARE is an important regulatory mechanism contributing to heparanase induction in human cancer.
authors.affiliation: Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
authors.forename: Gil
authors.initials: G
authors.lastname: Arvatz
authors.forename: Uri
authors.initials: U
authors.lastname: Barash
authors.forename: Ofer
authors.initials: O
authors.lastname: Nativ
authors.forename: Neta
authors.initials: N
authors.lastname: Ilan
authors.forename: Israel
authors.initials: I
authors.lastname: Vlodavsky
mesh_terms: D020413:3' Untranslated Regions / Q000235:genetics*; D015153:Blotting, Western; D002460:Cell Line; D045744:Cell Line, Tumor; D005786:Gene Expression Regulation / Q000235:genetics; D005966:Glucuronidase / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D020871:RNA Stability / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D000099175:Heparanase
chemical_list: D020413:3' Untranslated Regions; D005966:Glucuronidase; D012333:RNA, Messenger; D000099175:Heparanase
references.citation: Gene. 2000 Aug 8;253(2):171-8
references.pmid: 10940554
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):1028-36
references.pmid: 15709168
references.citation: Biochem Biophys Res Commun. 2007 Mar 2;354(1):33-8
references.pmid: 17208203
references.citation: Cell Cycle. 2005 Jul;4(7):908-13
references.pmid: 15917664
references.citation: J Clin Invest. 2001 Aug;108(3):341-7
references.pmid: 11489924
references.citation: Cancer Res. 2003 Dec 15;63(24):8821-6
references.pmid: 14695198
references.citation: Cell. 2009 Aug 21;138(4):673-84
references.pmid: 19703394
references.citation: Br J Pharmacol. 2007 May;151(1):1-14
references.pmid: 17339837
references.citation: J Cell Mol Med. 2007 May-Jun;11(3):427-52
references.pmid: 17635638
references.citation: Oncogene. 2005 Oct 13;24(45):6765-72
references.pmid: 16007175
references.citation: Pathophysiol Haemost Thromb. 2008;36(3-4):195-203
references.pmid: 19176992
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13613-7
references.pmid: 15342912
references.citation: Nat Med. 1999 Jul;5(7):803-9
references.pmid: 10395326
references.citation: Cancer Res. 2009 Mar 1;69(5):1758-67
references.pmid: 19244131
references.citation: Cancer Res. 2008 Dec 15;68(24):10077-85
references.pmid: 19074873
references.citation: Oncogene. 2003 Oct 30;22(49):7737-49
references.pmid: 14586400
references.citation: J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87
references.pmid: 17646672
references.citation: Blood. 2000 Oct 1;96(7):2528-36
references.pmid: 11001907
references.citation: Clin Cancer Res. 2007 Jul 15;13(14):4069-77
references.pmid: 17634531
references.citation: Cancer Res. 2003 Nov 15;63(22):7733-41
references.pmid: 14633698
references.citation: DNA Res. 2009 Feb;16(1):45-58
references.pmid: 19001483
references.citation: Int J Cancer. 2006 Apr 1;118(7):1609-17
references.pmid: 16217746
references.citation: Nat Rev Mol Cell Biol. 2001 Apr;2(4):237-46
references.pmid: 11283721
references.citation: Biochim Biophys Acta. 2001 Mar 21;1471(3):M99-108
references.pmid: 11250066
references.citation: Curr Pharm Des. 2007;13(20):2057-73
references.pmid: 17627539
references.citation: J Cell Sci. 2004 May 1;117(Pt 11):2249-58
references.pmid: 15126626
references.citation: Cancer Res. 2006 Feb 1;66(3):1455-63
references.pmid: 16452201
references.citation: Nucleic Acids Res. 2001 Jan 1;29(1):246-54
references.pmid: 11125104
references.citation: Int J Biochem Cell Biol. 2006;38(12):2018-39
references.pmid: 16901744
references.citation: Trends Biochem Sci. 1995 Nov;20(11):465-70
references.pmid: 8578590
references.citation: FASEB J. 2010 Apr;24(4):1239-48
references.pmid: 20007507
references.citation: J Biol Chem. 1999 Aug 20;274(34):24153-60
references.pmid: 10446189
references.citation: Pathophysiol Haemost Thromb. 2006;35(1-2):116-27
references.pmid: 16855356
references.citation: Nucleic Acids Res. 2006 Jan 03;33(22):7138-50
references.pmid: 16391004
references.citation: Pharmacol Ther. 2007 Apr;114(1):56-73
references.pmid: 17320967
references.citation: Cell Biochem Funct. 2008 Aug;26(6):676-83
references.pmid: 18646256
references.citation: Oncogene. 2006 Jun 29;25(28):3939-47
references.pmid: 16474844
references.citation: J Biol Chem. 2004 May 28;279(22):23536-41
references.pmid: 15044433
references.citation: Trends Biochem Sci. 2000 Aug;25(8):349-51
references.pmid: 10916150
references.citation: Curr Med Chem. 2006;13(18):2101-11
references.pmid: 16918340